Arbutus Biopharma Corp (ABUS) SG&A Expenses & History | Stock Alarm

Demo Sign up Log In

Arbutus Biopharma Corp · SG&A Expenses

ABUS SG&A Expenses

Latest reported$16.48Mperiod endingJun 30, 2026

ABUS SG&A Expenses ($1.33M → $16.48M)

Annual SG&A Expenses

High-resolution chart · PNG

ABUS sg&a expenses history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Arbutus Biopharma Corp SG&A Expenses — Annual fiscal periods (USD)
Period ending	SG&A Expenses (USD)
Dec 31, 2025	15,893,000
Dec 31, 2024	22,108,000
Dec 31, 2023	22,475,000
Dec 31, 2022	17,834,000
Dec 31, 2021	17,136,000
Dec 31, 2020	14,845,000
Dec 31, 2019	17,727,000
Dec 31, 2018	16,000,000
Dec 31, 2017	16,100,000
Dec 31, 2016	39,400,000
Dec 31, 2015	26,438,000
Dec 31, 2014	8,700,000
Dec 31, 2013	5,546,273
Dec 31, 2012	26,892,605
Dec 31, 2011	6,182,651
Dec 31, 2010	4,779,980
Dec 31, 2009	3,965,753
Dec 31, 2008	3,618,757
Dec 31, 2007	4,442,618
Dec 31, 2006	3,853,303
Dec 31, 2005	3,784,925
Dec 31, 2004	7,756,831
Dec 31, 2003	6,784,786
Dec 31, 2002	5,524,942
Dec 31, 2001	3,101,327
Dec 31, 2000	2,254,820
Dec 31, 1999	1,567,118
Dec 31, 1998	1,330,499

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.